Non-interventional Observational Study to Evaluate the Baseline FSH, Ovarian Volume and AFC (Antral Follicle Count) as Prognostic Factors of the Outcome of the In-vitro Fertilization/Intracytosolic Sperm Injection (IVF/ICSI) in Infertile Patients Who Receive r-FSH (GONAL-f) for Controlled Ovarian Hyperstimulation
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2013
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 21 Nov 2012 New source identified and integrated (German Clinical Trials Register).
- 27 Mar 2012 Actual patient number added 356 according to ClinicalTrials.gov.
- 27 Mar 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.